Metabolic Testing Market, By Product Type (Metabolic Carts, Body Composition Analyzers, ECGs/EKGs), By Test Type (VO2 Max Analysis, RMR Analysis, Body Composition Analysis), By End User (Hospitals and Clinics, Sports Performance Lab, Home Care Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI1652

Pages :179

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Market Challenge – Low Awareness among People Regarding Metabolic Testing

Lifestyle diseases are still not considered as extremely serious and fatal in developed as well as emerging economies. Low awareness among people regarding metabolic testing is significantly restraining the growth of the global metabolic testing market. Metabolic testing provides essential insights about an individual's metabolic health by measuring their body's ability to process energy, balance nutrients, and eliminate toxins. However, most people have very little understanding of what metabolic testing encompasses and how important it is for their overall well-being. Due to the lack of awareness, people do not seek metabolic testing voluntarily and even if doctors recommend it, patients remain hesitant to undergo these tests. They often perceive metabolic tests to be complex, tedious procedures requiring fasting, whereas modern testing methods have made the experience more convenient. This hinders the uptake of metabolic testing services. As a result, several underlying metabolic dysfunctions and nutritional deficiencies may remain undiagnosed. Over time, this can increase the risks of developing serious health issues like diabetes, obesity, cardiovascular diseases, and cancer.

Market Opportunity – Increasing Adoption of New Technologies in Metabolic Testing Devices

Increasing adoption of new technologies in metabolic testing devices is expected to drive growth of the global metabolic testing market. In May 2022, Mayo Clinic, a medical center focused on integrated health care, education, and research, developed a new app for Apple, a multinational technology company, using artificial intelligence to detect left-ventricular dysfunction, a life-threatening, asymptomatic heart disease. The introduction of ArtificiaI intelligence to 12 lead ECG (Electrocardiogram) analysis in a clinical setting enabled the ECG to identify left ventricular dysfunction. The technology has the potential to be scaled and adopted by hospital systems to better serve patients, particularly in remote communities or geographically diverse populations around the world.